About
Dale Kitchin is an immunologist whose research centers on antibody responses to HIV-1 and emerging viral pathogens, with a strong focus on African cohorts. Affiliated with leading South African research institutions in HIV immunology, this work integrates viral genetics, antibody repertoire sequencing, and vaccine evaluation to inform rational immunogen design and population-specific immunity.
Publications highlight key contributions to understanding virus–antibody co-evolution, broadly neutralizing antibody lineages targeting the V3-glycan and CD4 binding sites, and mechanisms such as isotype switching that counter viral escape. Studies in mucosal compartments and genital tract viral diversity further clarify how localized evolution shapes vaccine and microbicide efficacy.
Recent work extends to SARS-CoV-2 and HIV vaccine platforms, including Ad26.COV2.S breakthrough immunity and evaluation of HIV envelope immunogens in vervet models. Investigations into IGH polymorphism and copy number variation in South African populations underscore a commitment to uncovering genetic determinants of immune responsiveness and advancing globally relevant vaccine strategies.
AI Written based on the publications indexed for this author.
Metrics
4
Master’s students supervised
2
Doctoral students supervised